Developing Personalized Cancer Vaccines for ‘Cold’ Tumors to Create a Successful Therapy
Time: 11:30 am
day: Conference Day Two
Details:
- Turning cold tumors to hot by attracting immune cell infiltration and cytokine release with intratumorally infected oncolytic viruses
- Inducing tumor cell lysis to release the entire neoantigens of the tumor as personalized intratumor vaccination to broaden tumor specific T-cell repertoire.
- Employing a prime-boost strategy with tumor vaccine as a prime and intra-tumoral infection with oncolytic virus as a boost to enhance anti-tumor immunity
